Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for nonoxynol root_references_@count in root_references_@count (approximate match)

Showing 13901 - 13910 of 19755 results

First page
Previous page
Next page
Next page

FORDADISTROGENE MOVAPARVOVEC

H4T32JIH01

Status:

Investigational

Source:

NCT04281485: Phase 3 Interventional Active, not recruiting Duchenne Muscular Dystrophy

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04281485

Class:

STRUCTURALLY DIVERSE

CEVARETIGENE RITOPARVOVEC

KVF2UY1OR4

Status:

Investigational

Source:

INN:cevaretigene ritoparvovec [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/KVF2UY1OR4

Class:

STRUCTURALLY DIVERSE

IFEZUNTIRGENE INILPARVOVEC

VB2ZC1P6P4

Status:

Investigational

Source:

INN:ifezuntirgene inilparvovec [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/VB2ZC1P6P4

Class:

STRUCTURALLY DIVERSE

OLVIMULOGENE NANIVACIREPVEC

CF19SF72O5

Status:

Investigational

Source:

NCT02759588: Phase 1/Phase 2 Interventional Completed Ovarian Cancer

(2016)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02759588

Class:

STRUCTURALLY DIVERSE

LARUPARETIGENE ZOVAPARVOVEC

8OPK0FI6EM

Status:

Investigational

Source:

INN:laruparetigene zovaparvovec [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/8OPK0FI6EM

Class:

STRUCTURALLY DIVERSE

VOLRUBIGENE RALAPARVOVEC

8WI5RJ8D9V

Status:

Investigational

Source:

NCT03223194: Phase 1 Interventional Terminated Crigler-Najjar Syndrome

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03223194

Class:

STRUCTURALLY DIVERSE

Troculeucel

IZR558KO53

Status:

Investigational

Source:

NCT04578210: Phase 1/Phase 2 Interventional Completed Corona Virus Infection

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04578210

Class:

STRUCTURALLY DIVERSE

STAPULDENCEL

RB8MSD888P

Status:

Investigational

Source:

NCT03514836: Phase 1/Phase 2 Interventional Terminated Castration-resistant Prostate Cancer

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03514836

Class:

STRUCTURALLY DIVERSE

LENADOGENE NOLPARVOVEC

X0R16875YD

Status:

Investigational

Source:

NCT03406104: Phase 3 Interventional Completed Leber Hereditary Optic Neuropathy

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03406104

Class:

STRUCTURALLY DIVERSE

MVA-BN-BRACHYURY-TRICOM VACCINE

GD1ZWN2I2Y

Status:

Investigational

Source:

NCT03493945: Phase 1/Phase 2 Interventional Completed Metastatic Prostate Cancer

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03493945

Class:

STRUCTURALLY DIVERSE

Structurally Diverse

FORDADISTROGENE MOVAPARVOVEC

Structurally Diverse

CEVARETIGENE RITOPARVOVEC

Structurally Diverse

IFEZUNTIRGENE INILPARVOVEC

Structurally Diverse

OLVIMULOGENE NANIVACIREPVEC

Structurally Diverse

LARUPARETIGENE ZOVAPARVOVEC

Structurally Diverse

VOLRUBIGENE RALAPARVOVEC

Structurally Diverse

Troculeucel

Structurally Diverse

STAPULDENCEL

Structurally Diverse

LENADOGENE NOLPARVOVEC

Structurally Diverse

MVA-BN-BRACHYURY-TRICOM VACCINE

Showing 13901 - 13910 of 19755 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1